Antihypertensive agents 1962-1968.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001794:Blood Pressure / Q000187:drug effects*; D002090:Butyrophenones / Q000627:therapeutic use; D002395:Catecholamines / Q000378:metabolism; D003981:Diazoxide / Q000627:therapeutic use; D006146:Guanidines / Q000627:therapeutic use; D006571:Heterocyclic Compounds / Q000627:therapeutic use; D006801:Humans; D006867:Hydrolases / Q000037:antagonists & inhibitors; D007093:Imidazoles / Q000627:therapeutic use; D007211:Indoles / Q000627:therapeutic use; D008750:Methyldopa / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010455:Peptides / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011453:Prostaglandins / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D011799:Quinazolines / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use; D014166:Transferases / Q000037:antagonists & inhibitors; D014227:Triazines / Q000627:therapeutic use; D014443:Tyrosine / Q000037:antagonists & inhibitors
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D002090:Butyrophenones; D002395:Catecholamines; D006146:Guanidines; D006571:Heterocyclic Compounds; D007093:Imidazoles; D007211:Indoles; D008996:Monoamine Oxidase Inhibitors; D010455:Peptides; D010879:Piperazines; D011453:Prostaglandins; D011743:Pyrimidines; D011799:Quinazolines; D011804:Quinolines; D014227:Triazines; D014443:Tyrosine; D008750:Methyldopa; D011433:Propranolol; D014166:Transferases; D006867:Hydrolases; D003981:Diazoxide